Ali Ghasemi

Ali Ghasemi

Auto-generated profile, based on publicly available information

Ali Ghasemi

Power Plant Control Engineering Management, MAPNA Electric & Control Engineering & Manufacturing Company (MECO), Karaj, Iran

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2016 in Journal of Superconductivity and Novel Magnetism
Verified
Journal Article
Closed access
PDF file
STShahab Torkian
Shahab Torkian
AGAli Ghasemi
Ali Ghasemi
RRReza Shoja Razavi
Reza Shoja Razavi
MTMajid Tavoosi
Majid Tavoosi

3 January 2023 in Engineering Failure Analysis
Verified
Journal Article
Closed access
HGHosein Ghasemi
Hosein Ghasemi
EFElnaz Shahrabi Farahani
Elnaz Shahrabi Farahani
MFMahmud Fotuhi-Firuzabad
Mahmud Fotuhi-Firuzabad
Payman DehghanianPayman Dehghanian
Payman Dehghanian
AGAli Ghasemi
Ali Ghasemi
FWFei Wang
Fei Wang


28 March 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
AEAziz Eghbali
Aziz Eghbali
KGKazem Ghaffari
Kazem Ghaffari
AKAtefeh Khalilpour
Atefeh Khalilpour
RARoghayeh Rahimi Afzal
Roghayeh Rahimi Afzal
AEAygin Eghbali
Aygin Eghbali
AGAli Ghasemi
Ali Ghasemi

8 September 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
KGKazem Ghaffari
Kazem Ghaffari
AMAmin Moradi-Hasanabad
Amin Moradi-Hasanabad
ASAli Sobhani-Nasab
Ali Sobhani-Nasab
JJJavad Javaheri
Javad Javaheri
AGAli Ghasemi
Ali Ghasemi
Exosomes are small membrane vesicles of endocytic origin that are produced by both tumor and normal cells and can be found in physiological fluids like plasma and cell culture supernatants. They include cytokines, growth factors, proteins, lipids, RNAs, and metabolites and are important intercellular communication controllers in several disorders. According to a vast amount of research, exosomes could support or inhibit tumor start and diffusion in a variety of solid and hematological malignancies by paracrine signaling. Exosomes are crucial therapeutic agents for a variety of illnesses, such as cancer and autoimmune diseases. This review discusses the most current and encouraging findings from in vitro and experimental in vivo research, as well as the scant number of ongoing clinical trials, with a focus on the impact of exosomes in the treatment of malignancies. Exosomes have great promise as carriers of medications, antagonists, genes, and other therapeutic materials that can be incorporated into their core in a variety of ways. Exosomes can also alter the metabolism of cancer cells, alter the activity of immunologic effectors, and alter non-coding RNAs, all of which can alter the tumor microenvironment and turn it from a pro-tumor to an anti-tumor milieu. This subject is covered in the current review, which also looks at how exosomes contribute to the onset and progression of hematological malignancies, as well as their importance in diagnosing and treating these conditions.

15 February 2016 in Journal of Superconductivity and Novel Magnetism
Verified
Journal Article
Closed access
PDF file
STShahab Torkian
Shahab Torkian
AGAli Ghasemi
Ali Ghasemi
RRReza Shoja Razavi
Reza Shoja Razavi